The combination of MDMA and psychotherapy improved PTSD symptoms among participants in a phase 3 clinical trial, researchers reported at the spring meeting of the American Chemical Society.
Preliminary findings suggest that the combination works in hard-to-treat patients, including those with drug or alcohol use disorders, Jennifer Mitchell, PhD, principal investigator and professor of neurology at the University of California, San Francisco, and colleagues report.
According to Mitchell, the use of psychedelic drugs to treat these disorders is not new, and some psychiatrists used MDMA to